SCHEMBL8698799

SCHEMBL8698799

CCOC(=O)c1cn(Cc2ccccc2)nc1NC(=S)NC1CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.50
ALDH1A1 P00352 8/20 0.48
FAAH O00519 2/20 0.47
LMNA P02545 3/20 0.44
TDP1 Q9NUW8 1/20 0.44
ALOX12 P18054 1/20 0.44
GAA P10253 1/20 0.43
HTT P42858 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
CNR1 P21554 1/20 0.43
CNR2 P34972 1/20 0.43
EPHX2 P34913 1/20 0.42
STS P08842 1/20 0.42
POLB P06746 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8696204 0.91 FAAH (0.48) ALDH1A1FAAHLMNATDP1NPC1
SCHEMBL8696364 0.87 ALDH1A1 (0.49) ALDH1A1LMNAALOX12GAANPC1
SCHEMBL8692959 0.87 MAPT (0.54) MAPTALDH1A1FAAHLMNAALOX12
SCHEMBL8696385 0.85 MAPT (0.52) MAPTALDH1A1FAAHLMNATDP1
SCHEMBL14542033 0.85 PDE4B (0.49) MAPTALDH1A1FAAHLMNANPC1
SCHEMBL8692971 0.84 ALDH1A1 (0.42) ALDH1A1FAAHLMNATDP1GAA
SCHEMBL8693117 0.84 MAPT (0.50) MAPTALDH1A1FAAHLMNATDP1
SCHEMBL8693790 0.83 ALDH1A1 (0.44) MAPTALDH1A1FAAHLMNATDP1
SCHEMBL8695938 0.82 ALDH1A1 (0.47) MAPTALDH1A1LMNAALOX12GAA
SCHEMBL8694236 0.80 ALDH1A1 (0.46) MAPTALDH1A1LMNAALOX12GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5849779-A Pyrazole derivatives and their pharmaceutical use JAPAN ENERGY CORPORATION (JP) 1998-12-15 US disclosed
EP-0810217-A1 Pyrazole derivatives and their pharmaceutical use as smooth muscle cell growth inhibitors JAPAN ENERGY CORPORATION (JP) 1997-12-03 EP disclosed